Advanced search
Publication Cover
OncoImmunology Volume 6, 2017 - Issue 3
Submit an article Journal homepage
2,111
Views
23
CrossRef citations to date
0
Altmetric
Original Research

HLA class I-restricted MYD88 L265P-derived peptides as specific targets for lymphoma immunotherapy

Annika NeldeDepartment of Immunology, Institute for Cell Biology, University of Tübingen, Tübingen, Germany
,
Juliane Sarah WalzDepartment of Hematology and Oncology, University Hospital Tübingen, Tübingen, Germany
,
Daniel Johannes KowalewskiDepartment of Immunology, Institute for Cell Biology, University of Tübingen, Tübingen, Germany
,
Heiko SchusterDepartment of Immunology, Institute for Cell Biology, University of Tübingen, Tübingen, Germany
,
Olaf-Oliver WolzDepartment of Immunology, Institute for Cell Biology, University of Tübingen, Tübingen, Germany
,
Janet Kerstin PeperDepartment of Immunology, Institute for Cell Biology, University of Tübingen, Tübingen, Germany
,
Yamel Cardona GloriaDepartment of Immunology, Institute for Cell Biology, University of Tübingen, Tübingen, Germany
,
Anton W. LangerakDepartment of Immunology, Erasmus MC Rotterdam, Rotterdam, the Netherlands
,
Alice F. MuggenDepartment of Immunology, Erasmus MC Rotterdam, Rotterdam, the Netherlands
,
Rainer ClausDepartment of Hematology, Oncology and Stem Cell Transplantation, University Medical Center Freiburg, Freiburg, Germany
,
Irina BonzheimDepartment of Pathology, University Hospital Tübingen, Tübingen, Germany
,
Falko FendDepartment of Pathology, University Hospital Tübingen, Tübingen, Germany
,
Helmut Rainer SalihDepartment of Hematology and Oncology, University Hospital Tübingen, Tübingen, Germany;Clinical Cooperation Unit Translational Immunology, German Cancer Consortium (DKTK), DKFZ Partner Site Tübingen, Tübingen, Germany
,
Lothar KanzDepartment of Hematology and Oncology, University Hospital Tübingen, Tübingen, Germany
,
Hans-Georg RammenseeDepartment of Immunology, Institute for Cell Biology, University of Tübingen, Tübingen, Germany;German Cancer Consortium (DKTK), DKFZ Partner Site Tübingen, Tübingen, Germany
,
Stefan StevanovićDepartment of Immunology, Institute for Cell Biology, University of Tübingen, Tübingen, Germany;German Cancer Consortium (DKTK), DKFZ Partner Site Tübingen, Tübingen, Germany
&
Alexander N. R. WeberDepartment of Immunology, Institute for Cell Biology, University of Tübingen, Tübingen, GermanyCorrespondence[email protected]
 show all
Article: e1219825 | Received 01 Apr 2016, Accepted 28 Jul 2016, Published online: 03 Mar 2017

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.